Evercore ISI says increased reimbursement rates for COVID-19 vaccinations will boost revenue and operating profit for Rite Aid. Evercore ISI projects RAD will gain $95 million in sales and $45 million (+$0.80 / share) in operating profit through summer 2021 from COVID-19 vaccines. – chatter @ #wallstreetbets


This site uses Akismet to reduce spam. Learn how your comment data is processed.